Cornerstone Wealth Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Sell
31,186
-2,067
-6% -$317K 0.3% 94
2025
Q4
$4.58M Buy
33,253
+457
+1% +$59.8K 0.31% 92
2025
Q3
$4.21M Buy
32,796
+185
+0.6% +$22.6K 0.28% 92
2025
Q2
$3.95M Buy
32,611
+1,173
+4% +$132K 0.3% 93
2025
Q1
$3.5M Buy
31,438
+1,767
+6% +$188K 0.29% 96
2024
Q4
$2.89M Buy
29,671
+1,549
+6% +$165K 0.24% 98
2024
Q3
$3.23M Buy
28,122
+204
+0.7% +$23.1K 0.27% 93
2024
Q2
$2.97M Buy
27,918
+475
+2% +$47.7K 0.26% 90
2024
Q1
$2.65M Sell
27,443
-608
-2% -$62.3K 0.25% 94
2023
Q4
$2.83M Sell
28,051
-19,241
-41% -$1.86M 0.41% 73
2023
Q3
$4.82M Sell
47,292
-3,088
-6% -$313K 0.85% 31
2023
Q2
$5.08M Sell
50,380
-1,130
-2% -$113K 0.92% 34
2023
Q1
$4.74M Buy
51,510
+348
+0.7% +$30.4K 0.84% 38
2022
Q4
$4.64M Buy
51,162
+826
+2% +$69.6K 0.88% 35
2022
Q3
$3.83M Buy
+50,336
New +$4.17M 0.84% 42

Other funds holding NVS